For patients with established cardiovascular disease,aspirin is clearly beneficial as part of secondary prevention. However, when used as primary prevention in patients without documented cardiovascular disease, its benefit is much less certain. This podcast will explore 3 recent trials that evaluated aspirin in different populations and found nobenefit for its use as primary prevention.

Join us as we discuss a recent study of push-up capacity in middle-aged men and the association with CVD risk.

In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure.

In a recent study, data from the Cardiovascular Health Study examined the association between alcohol consumption and incident HF. It was found that moderate alcohol consumption was associated with a survival benefit, implying that individuals 65 years and older with newly diagnosed HF may not need to stop their alcohol use. Join the discussion about these findings and learn how they may impact the care of your patients with HF.

Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes.

Stroke can be devastating and lead to significant disability and/or death. Diagnosing and treating stroke symptoms as well as factors associated with transient ischemic attacks—often a stroke warning sign—are of paramount importance. The faculty in this talk will discuss the crucial role of the primary care team in post-stroke care and how you can ensure the best recovery for your patients who have suffered from stroke.

This talk will review the new ACC-AHA Hypertension guidelines and emphasize what’s old, what’s new, and what has changed.

Heart failure (HF) affects 5.7 million men and women in the United States, with 915,000 new cases occurring annually and a resultant 1,000,000 hospitalizations, which translates into an annual estimated cost of over $30 billion dollars. Mortality with this condition is high, approximately 50% at five years. Implementation of the advances in management of heart failure have the potential to improve patients' quality of life, reduce the need for hospitalizations, reduce total medical costs, and prolong survival. This lecture will review the current evidence-based, guideline recommended diagnosis and management of heart failure. The essential roles of evidence-based heart failure medications, device therapy, patient education, and disease management will be discussed.

The epidemiology of acute coronary syndromes has changed dramatically in the past few decades, with lower overall incidence of myocardial infarction (MI) -- particularly ST elevation MI -- and improved survival after an incident MI. The diagnosis and classification of MI is challenging, particularly in the era of sensitive troponin assays. Clinicians must be aware of the frequent occurrence and causes of troponin elevations from conditions other than MI. Following diagnosis, risk stratification for patients with non-ST elevation ACS is critical to making prudent decisions and selecting among the multitude of different options for invasive and medical therapies. When considering potent antiplatelet and antithrombotic therapies, it is of paramount importance to also consider bleeding risk. Primary care clinicians play a critical role in determining the optimal duration of dual antiplatelet therapy, ensuring appropriate use and adherence to evidence-based medical therapies, and addressing lifestyle factors that can help prevent or modify the course after an ACS event.

In this case presentation, Dr. Gluckman reviews a step-wise, evidence-based strategy for incorporating non-statin lipid-lowering therapy, such as PCSK9 inhibitors, in a patient who presents with an acute coronary syndrome as his initial manifestation of atherosclerotic cardiovascular disease (ASCVD).

Get your questions answered by expert faculty in Cardiology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.

Get your questions answered by expert faculty in Cardiology. You ask: we listen. You will learn practical solutions to common clinical challenges and tips to apply the latest knowledge in practice.